BD

Banshi Dhar Singh

Active Director Director DIN 10159128
DIN 10159128 First appointment May 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Banshi Dhar Singh

Data last updated:

Banshi Dhar Singh is a Director at Bhoo Sumrudhi Biotech Private Limited (since 2023). Bhoo Sumrudhi Biotech Private Limited reported revenue of ₹5.7 Lakh (FY 2025).

DIN 10159128
Primary Designation Director
First Appointment 11 May 2023
Oldest Company Age 3 yrs
Largest company Bhoo Sumrudhi Biotech Private Limited · ₹5.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 May 20232023₹5.7 Lakh (FY 2025)Active

Board colleagues of Banshi Dhar Singh

Directorship timeline

Open interactive timeline →
Bhoo Sumrudhi Biotech Private Limited
Premium access

Shareholding and investment profile for Banshi Dhar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Banshi Dhar Singh

Banshi Dhar Singh currently holds 1 directorship: Bhoo Sumrudhi Biotech Private Limited (Director, since 11 May 2023, revenue ₹5.7 Lakh (FY 2025)).

Banshi Dhar Singh was first appointed on 11 May 2023 as Director at Bhoo Sumrudhi Biotech Private Limited.

The current boards of Banshi Dhar Singh's companies include Amit Singh (Bhoo Sumrudhi Biotech Private Limited), Anil Kumar Singh (Bhoo Sumrudhi Biotech Private Limited), Anita Singh (Bhoo Sumrudhi Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available